US Stock MarketDetailed Quotes
RNAC Cartesian Therapeutics
- 27.175
- +2.425+9.80%
Trading May 15 12:37 ET
483.61MMarket Cap-484P/E (TTM)
27.440High24.940Low49.69KVolume24.940Open24.750Pre Close1.32MTurnover1.39%Turnover RatioLossP/E (Static)17.80MShares36.92052wk High-4.14P/B97.43MFloat Cap11.66552wk Low--Dividend TTM3.59MShs Float728.003Historical High--Div YieldTTM10.10%Amplitude11.665Historical Low26.535Avg Price1Lot Size
About Cartesian Therapeutics Company
Cartesian Therapeutics, Inc. operates as a clinical-stage biotechnology company. It provides RNA cell therapies for the treatment of autoimmune diseases. The company is headquartered in Gaithersburg, MD.
Company Profile
SymbolRNAC
Company NameCartesian Therapeutics
Listing DateJun 22, 2016
CEODr. Carsten Brunn, PhD
MarketNASDAQ
Employees38
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address704 Quince Orchard Road
CityGaithersburg
ProvinceMaryland
CountryUnited States of America
Zip Code20878
Company Executives
- Name
- Position
- Salary
- Dr. Carsten Brunn, PhD
- Director, President and Chief Executive Officer
- 6.11M
- Blaine Davis
- Chief Financial Officer and Principal Accounting Officer
- 2.49M
- Dr. Milos Miljkovic, M.D.
- Chief Medical Officer
- --
- Dr. Christopher M. Jewell, PhD
- Chief Scientific Officer
- 53.10K
- Dr. Metin Kurtoglu, M.D.,PhD
- Chief Technology Officer
- 5.37K
- Dr. Emily English, PhD
- Senior Vice President and Head of Manufacturing
- --
- Carrie S. Cox
- Chairman of the Board
- 292.32K
- Dr. Timothy A. Springer, M.D.,PhD
- Director
- 192.73K
- Patrick J. Zenner
- Independent Director
- 192.05K
- Timothy C. Barabe
- Independent Director
- 212.93K
- Dr. Michael Singer, M.D.,PhD
- Independent Director
- 5.71K
- Dr. Nishan de Silva, M.B.A.,M.D.
- Independent Director
- 188.58K
- Dr. Murat Kalayoglu, M.D.,PhD
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
